REFERENCIAS BIBLIOGRÁFICAS
1. Arders H. Molecular genetics as the
route to understanding, prevention, and treatment. Lancet 1996; 348: S17-9. 4 Lindpaintner K, Pfeffer MA, et aI.A prospective evaluation of an angiotensin converting enzyme gen polymorphism and the risk of ischaernic heart disease. N Englj Med 1995; 332: 706-11. 5. Nakai K, Itoh C, et al. Deletion polymorphisin of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for coronary artery desease in the japanese. Circulation 1994; 90:2199-202. 6. Mattu RK etal.A DNAvariant atthe angiotensin-converting enzymegene locus associates with coronaryartery desease in the caerphilly heart study. Circulation 1995; 91: 250-4. 7. KrejejH, Kim HS et al.Angiotensin-converting enzyme gene mutations, blood pressure, and cardiovascular homeostasis. Hypertension 1997;29(p2):150-7. 8. MatsusakTHymesj,etal.Angiotensin in progressive renal disease:Theory and practicej Am Soc. Nelphrol 1996; 7:2025-43. 9. Raynolds MY, Bristow MR,et al.Angiotensin-converting enzyme DID genotype in patients with ischearnic or idiopathic dilated cardiomopathy. Lancet 1993; 342: 1073-5. 10. Ruizj, Blanche H.,et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 9 1: 3662-5. 11. Ohishi, et al A potent genetic risk factor for reestenos is (letter). Nature Genet 1993; 5: 324-5. 12 Arbustini E, Grasso, et al. Angiotensin converting enzyme deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995; 74:584-9 1. 13. Cambien F, Cousterousse 0, et al. Plasma levels and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90:669-76. 14. Takahashi L, Nakamura H, et al.Association of ACE gene polymorphisms with coronary artery clesease in a Northern Area of Japan j pn HeartJ 1995;36:557-64. 15. GardemanA, Fink M, et alACE I/D gene polymorphisin: presence of theACED allele increases the risk of coronary artery clesease in younger individuals. Atherosclerosis 1998; 139: 153-9. 16. Ludwig E,Corneli PS,etalAngiotensin converting enzyme gene polymorphism is associated with myocardial infarction butnotwith clevelopmentof coronary stenosis, Circulation 1995; 91: 2120-4. 17. Wang XL, Mc.Credie KM,et al. Genotype distribution of angiotensin-converting enzyme polimorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery desease.Arterioscler ThrombVasc Biol 1996; 26:115-9. 18 Schachter Y Fare-Delanef L. et al. Genetic association with human Longevity at the APO E and ACE loci. Nature Genet. 1994; 6:29-32. 19. Evans, DE, Poiser O. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart clesease. Quart J Med 1994;87:211-4. 20. Oike et al angiotensin converting enzyme as a genetic risk factor for coronary artery spasm: implication in the pathogenesis of myocardial irifarction.j Clin Invest 1995; 96:2975-9. 21. Bohn,M.et al. Insertion/deletion (I/D) polymorphism atthe locus for angioten sin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44: 298-301. 22. Amant, et al. D allele of the angiotensin I-converting enzyme is a major risk factor to reestenosis after coronary stenting, Circulation 1997; 96:56-60. 23. Samani N,Thompson JR. et al.A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12. 24. Bohn M, et al. Insertion/deletion polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction.Clin Genet 1993;44:292-7. 25. FriedlWKrempler FetaIA deletion polymorphism in the angiotensin converting enzyme gen is not associated with the coronary heart clesease in an Australian population.Atherosclerosis 1995; 112: 137-43. 26. Agerholm-Larsen B, et al. ACE gene polymorphism: ischaemic desease and longevity in 10150 individuals.A case referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 1997; 95: 2358-67. 27. Pfohl M, Koch M, etal.Angiotensin I-converting enzyme gene polymorphism,coronary artery clesease and myocardial infarction. Eur HeartJ 1999; 20: 13 18-25, 28. Gardeman A, Stricker J, Humme J, Nguyen QD et al.Angiotensinogen T I 74M and M23ST gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis 1999; 145: 309-14. 29. Winkelmann BK, Russ AP, Nauck M, Klein B, et al. Angiotensinogen M23ST polymorphism is associated with plasma angiotensinogen and cardiovascular disease.Am Heart J 1999; 137: 698-705. 30. Ludwig EH, Borecki IB, Ellison KC, et al.Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary artery disease and myocardial infarction:the NHLBI family Heart study.Ann Epidemiol 1997; 7: 3-12. 31. Jeunematre X, Soubrier F, KotelevtsevYV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-80. 32. Oliveri 0, Stranieri C, Girelli D, et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multivessel coronary artery diseaseJ Hypertens 200 1; 19:879-84. 33. Kakutani M, Masaki T Sanamura T.A platelet-endothelium interaction mediated by lectin like oxidized low-density lipoprotein receptor-1. Proc Nad Acad Sci 2000; 97:360-4. 34. Morawietz H, Rueckschloss U, Nieman B, et al.Angiotensin II induces LOX-I, the human enclothelial receptorfor oxidized low-density lipoprotein.Circulation 1999; 100: 899-902. 35. Ortlepp J,Janss(Ins V, Bleckmann F, et al. A Chymase gene is associated with atherosclerosis in venous coronary artery bypass grafts. CoronaryArtery Dis 2001; 12:493-7. 36. Uehara Y Urata H, Sasarin M, Ideishi M, etal.increase Chymase activity in thoracic artery of patients with hypercholesterolernia. Hypertension 2000; 35:50-60. 37 Cambien F, Lecerf L, Evans A, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent riskfactorfor myocardial infarction. Nature 1962; 359:641-4. 38. Fujita R. Localisation du géne de I'ataxie de Friedreich par sa liaison génétique et physique avec les loci D955 et D9551I S. Tesis para obtener el titulo de PhD. Universidad Louis Pasteur, Strasbourg, Francia. 1991. 39. Rigat B, Hubert C, Corvol P, Soubrier F PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase I). Nucleic Acids Res 1962; 20(6): 1433. 40. Young MJ, et al. Simple Size Nomogramsfor Interpreting Negative Clinical Studies. Ann Intern Med 1983; 99: 248-51. 41. Cong NDHamaguchi K,SalkawaTSakataTA poiymorphism of angiotensinogen gene codon 174 and coronary artery disease injapanese subjectsAmJ Med Sci 1996; 316:339-44. 42. Ichih irajYokota M,Fujimura Fet al.Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men.Am Heart J 1997; 134; 260-5. 43 GarciemanA,Str ckerj, Hummej, Nguyen QD,Philipp M,et ai.Angiotensinogen T174 M and M23ST gene polymorphisms are associated with the extent of coronary atherosclerosis.Atherosclerosis 1999; 145: 309-14. 44. Keauney B, Mckenzie C, Parish S, Palmer A et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls: International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355: 434-42. 45 Arca M, Pannitteri G, Campagna F, Candeloro, et al. Angiotensin-converting-enzyme gene polymorphism is associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients. Eur J Clin Invest 1998; 28: 485-90. 46. FerrieresJ, Ruidavets JB, Fauvel J, Ferret B,et al.Angiotensin 1-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease. Atherosclerosis. 1999; 142:211-6. 47. 0'Malley JP, Maslen CL, Illingworth DR. Angiotensin-converting enzyme and cadiovascular disease risk. Curr Opin Lipidol 1999; 10: 407-15. 48. Petrovic DZorc M, KauricVPeterlin B.Interaction between gene polymorphisms of renin-angiotensin system and metabolic riskfactor in premature myocardial infarction.Angiology 2000; 52: 247-52. 49. Wenzel K, Blackburn A, Ernest M, Affeldt M, Hanke R, Bruman G, et al. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary artery disease Mol Med 1997; 75:57-61. 50. Sheu WH, Lee WJ, Jeng CY, et al. Angiotensinogen gene polymorphism 'in associated with insulin resistance in non diabetic men with orwithout coronary heart disease.Am HeartJ 1999; 136:125-31. 51. Su EJ, Schwartz SM, etal. Angiotensin II inducesvascular smooth cell replication independent of blood pressure. Hypertension. 1998; 31: 1331-37. 52. De Blois D, Lombardi DM, Su EJ, Schwartz ST et al.Angiotensin II induction of osteoporosis expression and DNA replication in rat arteries. Hypertension 1996; 28: 1055-63.
|